Director, Patient Centered Outcomes
New Yesterday
Director, Patient Centered Outcomes
Posted Date: Dec 4 2025
Locations: Upper Providence, PA; GSK HQ or Stevenage, UK. Hybrid 2-3 days per week. Additional flexible arrangements considered on a case‑by‑case basis.
Job Purpose: As a Director of Patient‑Centered Outcomes (PCO) you will apply technical expertise to plan and support evidence development strategies for Patient Reported Outcomes (PRO)/Clinical Outcome Assessment (COA)‑related endpoints across GSK’s portfolio. The PCO team plays an integral role in the development of integrated evidence plans to ensure that strong PRO/COA strategies support a patient‑centric understanding of our drug development across Respiratory, Immunology and Inflammation, Infectious Diseases, Vaccines and Oncology. Our mission is to deliver by implementing strong measurement science to capture the patient voice in demonstrating the value of our products to patients, physicians, payers, and regulators.
The team has educational backgrounds across a range of PRO/COA disciplines and experience in pharmaceutical, regulatory, and academic settings. We work in a matrix environment with close partnership across GSK functions including Clinical Development, Regulatory Affairs, Biostatistics, Medical Affairs, Commercial and Patient Focused Development. We are well connected with external initiatives exploring innovative approaches to define, implement and interpret patient centric endpoints in drug development.
The PCO team maintains a sharp focus on the value of patient‑centric outcomes across the portfolio. We want to ensure that each clinical program has a well‑characterized, innovative PRO/COA strategy that is defined early in the development lifecycle and has clear plans to develop evidence that supports PRO/COA‑related endpoints.
Key Responsibilities
- Define and oversee the execution of strategies for the rigorous development and implementation of PRO/COAs across GSK’s portfolio.
- Guide the development, validation, analysis, interpretation, and utilization of PRO/COA instruments in the context of clinical trials and/or observational studies.
- Work cross‑functionally (e.g., clinical operations, biostats teams) to ensure the value of patient‑centric endpoints is communicated clearly and that PRO/COAs are implemented and analyzed appropriately in clinical trials (and are accurately described in statistical analysis plans, study reports and publications).
- Support key communications with regulatory bodies by developing targeted questions related to the PRO/COA endpoint strategy and identifying the critical evidence needed for meetings to support GSK’s patient‑centric endpoint strategies.
- Support broader publication strategy by planning for and contributing to external publications (e.g., scientific abstracts and peer‑reviewed manuscripts) which present PRO‑related results from clinical trials and/or PRO development and validation studies.
- Maintain awareness of scientific and regulatory changes across GSKs drug development programs.
- Pursue ongoing learning to understand and adopt evolving methodologies and guidelines (including those from regulatory authorities) and communicate findings to functional groups as needed.
Basic Qualifications
- Master’s or Doctoral degree in Psychology, Psychometrics, Social Sciences, Outcomes Research, Health services research, Public Health, Epidemiology, Pharmacy, or a closely related discipline.
- 7+ years of experience in a related role, including demonstrated experience with PRO/COA development and implementation in a consulting and/or pharmaceutical company environment.
- Experience in pharmaceuticals, particularly in drug and vaccine development, with demonstrated experience in clinical trial planning and execution.
- Experience with FDA Patient Focused Drug Development Guidance.
- Experience with planning and managing PRO development and validation projects.
- Experience in inclusion of COA endpoints in clinical trials and analysis of PRO data.
- Experience in managing internal stakeholders through to executive levels.
- Working knowledge or experience in psychometric methods for the validation of PROs/COA endpoints.
- Working knowledge or experience in the evolving methods and regulatory environment with respect PRO/COA.
Preferred Qualifications
- Understanding of healthcare markets and regulatory and reimbursement decision making, especially in relation to the global use of PRO data in drug and vaccine development.
- Strong verbal and written communication skills.
Benefits: Please visit GSK US Benefits Summary to learn more about the comprehensive benefits program GSK offers US employees.
Why GSK? Uniting science, technology and talent to get ahead of disease together. GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive. We get ahead of disease by preventing and treating it with innovation in specialty medicines and vaccines. We focus on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases – to impact health at scale. People and patients around the world count on the medicines and vaccines we make, so we’re committed to creating an environment where our people can thrive and focus on what matters most. Our culture of being ambitious for patients, accountable for impact and doing the right thing is the foundation for how, together, we deliver for patients, shareholders and our people.
If you require an accommodation or other assistance to apply for a job at GSK, please contact the GSK Service Centre at 1‑877‑694‑7547 (US Toll Free) or +1 801 567 5155 (outside US).
GSK is an Equal Opportunity Employer. This ensures that all qualified applicants will receive equal consideration for employment without regard to race, color, religion, sex (including pregnancy, gender identity, and sexual orientation), parental status, national origin, age, disability, genetic information (including family medical history), military service or any basis prohibited under federal, state or local law.
- Location:
- Greater London
- Salary:
- £125,000 - £150,000
- Job Type:
- FullTime
- Category:
- Bio & Pharmacology & Health
We found some similar jobs based on your search
-
New Yesterday
Director, Patient Centered Outcomes
-
Greater London, England, United Kingdom
-
£125,000 - £150,000
- Bio & Pharmacology & Health
Director, Patient Centered Outcomes Posted Date: Dec 4 2025 Locations: Upper Providence, PA; GSK HQ or Stevenage, UK. Hybrid 2-3 days per week. Additional flexible arrangements considered on a case‑by‑case basis. Job Purpose: As a Director of Pa...
More Details -
-
New Yesterday
Director, Patient-Centered Outcomes & PRO Strategy
-
Greater London, England, United Kingdom
-
£125,000 - £150,000
- Bio & Pharmacology & Health
A global biopharma company is seeking a Director of Patient Centered Outcomes to lead the development and implementation of evidence strategies for patient-reported outcomes. The role requires strong expertise in PRO/COA development within a pharmace...
More Details -
-
32 Days Old
Patient Centered Outcomes HTA, TA Director (4 open roles)
-
City Of London, England, United Kingdom
-
£125,000 - £150,000
- Bio & Pharmacology & Health
The PCO HTA TA Director will oversee one therapeutic area (e.g., CRM, immunology, oncology, or neurosciences) and their responsibility will span multiple assets/indications. The Director will cultivate a strong partnership with team members from internal groups incl. Access, Clinical Development, PCO COE, and Medical Affairs.
More Details -
-
35 Days Old
Patient Centered Outcomes HTA, TA Director (4 open roles)
-
City Of London, England, United Kingdom
-
£125,000 - £150,000
- Bio & Pharmacology & Health
The Patient Centered Outcomes (PCO) HTA, TA Director within the HEOR TA teams, in partnership with HEOR leads co-leads the PCO reimbursement strategy. The PCO HTA TA Director will oversee one therapeutic area (e.g., CRM, immunology, oncology, or neurosciences) and their responsibility will span multiple assets/indications. The Director...
More Details -